SCHEMBL688419

SCHEMBL688419

CCCc1cn(Cc2c(Cl)cccc2OCC)c(=O)c(NC(=O)N[C@@H](CC(=O)O)c2cccc(OC(C)C)c2)c1O

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
KMT2A Q03164 2/20 0.34
P2RX3 P56373 6/20 0.33
KCNB1 Q14721 2/20 0.33
KCNK2 O95069 1/20 0.33
KCNA5 P22460 1/20 0.33
KCNH2 Q12809 1/20 0.33
FFAR1 O14842 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
PTGER3 P43115 2/20 0.32
PPARG P37231 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL687724 0.95 SMN1; SMN2 (0.36) SMN1; SMN2KMT2AKCNB1FFAR1KDM4E
SCHEMBL686761 0.92 SMN1; SMN2 (0.37) SMN1; SMN2KMT2AKDM4EALDH1A1CYP2C9
SCHEMBL688582 0.91 SMN1; SMN2 (0.39) SMN1; SMN2KMT2AFFAR1KDM4EALDH1A1
SCHEMBL687119 0.91 SMN1; SMN2 (0.36) SMN1; SMN2KMT2AP2RX3KCNB1KCNK2
SCHEMBL688331 0.90 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AKCNB1FFAR1KDM4E
SCHEMBL687713 0.89 CTSA (0.37) SMN1; SMN2KMT2AKDM4EALDH1A1
SCHEMBL687801 0.88 FFAR1 (0.35) SMN1; SMN2KMT2AP2RX3FFAR1KDM4E
SCHEMBL687913 0.88 SMN1; SMN2 (0.47) SMN1; SMN2KMT2AALDH1A1PTGER3
SCHEMBL687573 0.87 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AP2RX3KCNB1KCNK2
SCHEMBL687970 0.87 SMN1; SMN2 (0.41) SMN1; SMN2KMT2AKCNB1FFAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed